AGP Executive Report
Last update: 9 hours agoEpilepsy Research: Chinese scientists report a first human trial of a gene-based treatment that uses a drug-activated switch to suppress seizures in people with drug-resistant epilepsy, offering a possible alternative to removing brain tissue. Outbreak Response: A dengue outbreak at construction sites in Hainan has led to thousands of workers being quarantined. Medical AI: New AI tools for imaging, surgical planning and chronic-disease care are on display at the Shanghai import expo, with hospitals and companies exploring clinical use. Air Quality: China’s tighter air-pollution standards could prevent more than 200,000 deaths, according to a recent analysis. Drug Access: China approved its first golimumab biosimilar, adding a lower-cost option for patients with inflammatory diseases. Long-Term Care: New guidelines aim to improve how China’s long-term care insurance system pays for services.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
